UK markets open in 6 hours 6 minutes
NIKKEI 225
38,137.85 -91.26 (-0.24%) HANG SENG
18,963.68 +425.88 (+2.30%) CRUDE OIL
78.04 -0.22 (-0.28%) GOLD FUTURES
2,370.00 -5.00 (-0.21%) DOW
39,512.84 +837.14 (+2.16%) Bitcoin GBP
49,137.39 +438.50 (+0.90%)
Compass Therapeutics, Inc. (CMPX)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 220.14M |
| Enterprise value | 69.41M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 1.48 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -8.92 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.73 |
| 52-week change 3 | -51.81% |
| S&P500 52-week change 3 | 26.27% |
| 52-week high 3 | 3.6200 |
| 52-week low 3 | 1.1500 |
| 50-day moving average 3 | 1.7826 |
| 200-day moving average 3 | 1.8506 |
Share statistics
| Avg vol (3-month) 3 | 350.57k |
| Avg vol (10-day) 3 | 245.33k |
| Shares outstanding 5 | 137.59M |
| Implied shares outstanding 6 | 137.59M |
| Float 8 | 102.88M |
| % held by insiders 1 | 12.04% |
| % held by institutions 1 | 62.77% |
| Shares short (30 Apr 2024) 4 | 1.64M |
| Short ratio (30 Apr 2024) 4 | 4.96 |
| Short % of float (30 Apr 2024) 4 | 1.69% |
| Short % of shares outstanding (30 Apr 2024) 4 | 1.19% |
| Shares short (prior month 28 Mar 2024) 4 | 1.62M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -17.66% |
| Return on equity (ttm) | -25.74% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -49.66M |
| Net income avi to common (ttm) | -42.49M |
| Diluted EPS (ttm) | -0.3300 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 152.46M |
| Total cash per share (mrq) | 1.11 |
| Total debt (mrq) | 1.73M |
| Total debt/equity (mrq) | 1.17% |
| Current ratio (mrq) | 19.73 |
| Book value per share (mrq) | 1.16 |
Cash flow statement
| Operating cash flow (ttm) | -40.62M |
| Levered free cash flow (ttm) | -25.2M |
© 2024 Yahoo. All rights reserved.